Dr. Eric Kelsic, CEO and co-founder of Dyno Therapeutics, explains how AI could reduce the cost of gene therapy delivery to $0.

Benralizumab, a monoclonal antibody, is the first breakthrough in asthma and COPD flare-up treatment in 50 years. Targeting ...

To learn more about the new method, Technology Networks attended RAFA 2024 to hear from one of its pioneers, Sofia ...

A study suggests depression causes menstrual pain, supported by genetic evidence linking the two conditions. Researchers ...

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more ...

A University of Liverpool study links Alzheimer’s disease to disrupted mechanical signaling between proteins APP and talin in ...

A groundbreaking international study shows how chemical fingerprints left by “underappreciated” aquatic organisms could help scientists monitor global environmental change.

A University of Bristol study found that automated insulin delivery systems for Type 1 Diabetes often miss critical ...

A study by ISGlobal links air pollution (PM2.5, PM10) to persistent long-COVID symptoms, particularly severe cases. Findings ...

Chimpanzees display an early form of cumulative culture, with successive generations refining tool-use practices for complex ...

NYU Langone researchers found cancer cells resist chemotherapy in low-glucose environments by conserving pyrimidines and ...

A new study indicates that the loss of brain volume associated with the Alzheimer's drug lecanemab shows the drug is working ...